Transcriptional regulation of the Bach2 B-cell differentiation and apoptotic factor by the Bcr-Abl oncoprotein.

被引:0
|
作者
Makri, M
Yoshida, C
Muto, A
Igarashi, K
Melo, JV
机构
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2991
引用
收藏
页码:838A / 838A
页数:1
相关论文
共 50 条
  • [41] Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2
    Hodson, Daniel J.
    Shaffer, Arthur L.
    Xiao, Wenming
    Wright, George W.
    Schmitz, Roland
    Phelan, James D.
    Yang, Yandan
    Webster, Daniel E.
    Rui, Lixin
    Kohlhammer, Holger
    Nakagawa, Masao
    Waldmann, Thomas A.
    Staudt, Louis M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (14) : E2039 - E2046
  • [42] THE SH2 DOMAIN OF ABL IS NOT REQUIRED FOR FACTOR-INDEPENDENT GROWTH INDUCED BY BCR-ABL IN A MURINE MYELOID CELL-LINE
    ODA, T
    TAMURA, S
    MATSUGUCHI, T
    GRIFFIN, JD
    DRUKER, BJ
    LEUKEMIA, 1995, 9 (02) : 295 - 301
  • [43] POLYCLONAL B-CELL ACTIVATION BY B-CELL DIFFERENTIATION FACTOR B151-TRF2
    ONO, S
    TAKAHAMA, Y
    HAMAOKA, T
    JOURNAL OF IMMUNOLOGY, 1986, 137 (04): : 1149 - 1156
  • [44] Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas
    Liu, Jinghua
    Sorensen, Annette Balle
    Wang, Bruce
    Wabl, Matthias
    Nielsen, Anders Lade
    Pedersen, Finn Skou
    BMC MOLECULAR BIOLOGY, 2009, 10
  • [45] PHILADELPHIA-CHROMOSOME POSITIVE B-CELL TYPE MALIGNANT-LYMPHOMA EXPRESSING AN ABERRANT 190 KDA BCR-ABL PROTEIN
    MITANI, K
    SATO, Y
    TOJO, A
    ISHIKAWA, F
    KOBAYASHI, Y
    MIURA, Y
    MIYAZONO, K
    URABE, A
    TAKAKU, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 221 - 225
  • [46] The B cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs.
    Ito, E
    Kamio, T
    Toki, T
    Kanezaki, R
    Sasaki, S
    Tandai, S
    Terui, K
    Ikebe, D
    Igarashi, K
    BLOOD, 2003, 102 (11) : 592A - 592A
  • [47] B-Cell-Specific Transcription Factor BACH2 Involved in the Clinical Behavior Heterogeneity of Waldenstrom Macroglobulinemia
    Herbaux, Charles
    Marot, Guillemette
    Bertrand, Elisabeth
    Broucqsault, Natacha
    Zouitna-Galiegue, Sylvie
    Roumier, Christophe
    Poret, Nicolas
    Soenen, Valerie
    Nibourel, Olivier
    Roche-Lestienne, Catherine
    Renneville, Aline
    Boyle, Eileen
    Fouquet, Guillemette
    Tricot, Sabine
    Preudhomme, Claude
    Quesnel, Bruno
    Poulain, Stephanie
    Leleu, Xavier
    BLOOD, 2012, 120 (21)
  • [48] Prognostic significance of BACH2 expression in diffuse large B-cell lymhomna: A study of the Osaka Lymphoma Study Group
    Sakane-Ishikawa, E
    Nakatsuka, S
    Tomita, Y
    Fujita, S
    Nakamichi, I
    Takakuwa, T
    Sugiyama, H
    Fukuhara, S
    Hino, M
    Kanamaru, A
    Soma, T
    Tsukaguchi, M
    Igarashi, K
    Kanakura, Y
    Aozasa, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8012 - 8017
  • [49] SIMULTANEOUS OCCURRENCE OF A ETV6-RUNX1 AND BCR-ABL (E1A2) TRANSCRIPTS IN A CHILD WITH A B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Balatzenko, G.
    Guenova, M.
    Kalinova, I.
    Belcheva, M.
    Hristozova, H.
    Kaleva, V.
    HAEMATOLOGICA, 2012, 97 : 485 - 485
  • [50] Pro-apoptotic protein bax is involved in the development of B-cell acute lymphoblastic leukemia induced by BCR/ABL oncogene in mice
    Li, SG
    Lu, YG
    BLOOD, 2002, 100 (11) : 211B - 211B